Chemistry & Biology
Volume 17, Issue 1, 29 January 2010, Pages 46-56
ArticleToward the Rational Design of p53-Stabilizing Drugs: Probing the Surface of the Oncogenic Y220C Mutant
Under an Elsevier user license
open archive
Graphical Abstract
Highlights
► Ligand-binding sites on p53 mutant Y220C identified by fragment screening and MD ► Crystallographic binding modes of fragment hits solved, showing key interactions ► Plasticity of cavity site highlights link between protein flexibility and stability ► Fragment hits reduce simulated protein dynamics, thus stabilizing local structure
CHEMBIO
CELLCYCLE
HUMDISEASE
Cited by (0)
- 2
These authors contributed equally to this work
Copyright © 2010 Elsevier Ltd. All rights reserved.